Biogen (BIBB) volatility low; shares rally 20% on positive MS drug data and profit up 35%
Tweet Send to a Friend
Biogen (Nasdaq: BIIB) announced on its earnings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
